Sipagladenant (Compound I) is an orally active
[1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf•sfvrsn=8544ca1e_3&download=true
[2]. Horita, Takako. THERAPEUTIC AGENT FOR FRONTAL LOBE DYSFUNCTION, WO2016148308A1.
















